Syntone Ventures Llc - Net Worth and Insider Trading
Syntone Ventures Llc Net Worth
The estimated net worth of Syntone Ventures Llc is at least $6 Million dollars as of 2024-11-13. Syntone Ventures Llc is the 10% Owner of Outlook Therapeutics Inc and owns about 991,152 shares of Outlook Therapeutics Inc (OTLK) stock worth over $6 Million. Details can be seen in Syntone Ventures Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Syntone Ventures Llc has not made any transactions after 2021-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Syntone Ventures Llc
Syntone Ventures Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Syntone Ventures Llc owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Syntone Ventures Llc’s form 4 insider trades.
Insider Ownership Summary of Syntone Ventures Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-02-03 | 10 percent owner |
Syntone Ventures Llc Latest Holdings Summary
Syntone Ventures Llc currently owns a total of 1 stock. Syntone Ventures Llc owns 991,152 shares of Outlook Therapeutics Inc (OTLK) as of February 3, 2021, with a value of $6 Million.
Latest Holdings of Syntone Ventures Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-02-03 | 991,152 | 6.27 | 6,214,523 |
Holding Weightings of Syntone Ventures Llc
Syntone Ventures Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Syntone Ventures Llc has made a total of 2 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 150,000 shares on February 3, 2021, which cost Syntone Ventures Llc around $3 Million.
Insider Trading History of Syntone Ventures Llc
- 1
Syntone Ventures Llc Trading Performance
GuruFocus tracks the stock performance after each of Syntone Ventures Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Syntone Ventures Llc is 11.79%. GuruFocus also compares Syntone Ventures Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Syntone Ventures Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Syntone Ventures Llc's insider trading performs compared to the benchmark.
Performance of Syntone Ventures Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.09 | | | | | |
| Relative Return to S&P 500(%) | 16.96 | | | | | |
Syntone Ventures Llc Ownership Network
Ownership Network List of Syntone Ventures Llc
Ownership Network Relation of Syntone Ventures Llc
Syntone Ventures Llc Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Syntone Ventures Llc is the 10 percent owner of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Syntone Ventures Llc made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Syntone Ventures Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Syntone Ventures Llc. You might contact Syntone Ventures Llc via mailing address: 1517 Champlain Crest Way, Cary Nc 27513.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
